TickerFactsScreenerDevelopers

Corvus Pharmaceuticals, Inc. (CRVS) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2015: $1.75M2016: $2.20M2017: $266.0K2018: $355.0K2019: $25.0K2020: $76.0K2021: $5.0K2022: $269.0K2023: $34.0K2025: $174.0K$174.0K
2015Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$174.0K—
2023$34.0K-87.4%
2022$269.0K+5280.0%
2021$5.0K-93.4%
2020$76.0K+204.0%
2019$25.0K-93.0%
2018$355.0K+33.5%
2017$266.0K-87.9%
2016$2.20M+25.9%
2015$1.75M—